Hing B, Braun P, Cordner ZA, Ewald ER, Moody L, McKane M, Willour VL, Tamashiro KL, Potash JB
Huperzine A: A promising anticonvulsant, disease modifying, and memory enhancing treatment option in Alzheimers disease
Key Takeaways IGF-1 LR3 has a half-life of 2030 hours due to reduced IGF-binding protein affinity, enabling sustained systemic IGF-1 receptor activation without growth hormone involvement
Glutathione is one of the main endogenous antioxidants, acting in the body to recycle other antioxidants and protect the body from free radicals, as well as support detoxification
Paik, J
GHRP-2 has more clinical dosing data due to its use as a diagnostic agent in Japan (Simple diagnostic test using GHRP-2, 2007), while GHRP-6 has detailed pharmacokinetic characterization from a healthy volunteer study (PK study of GHRP-6, 2012)